lipoicmethylenedioxyphenol

Lipoicmethylenedioxyphenol (LMDP) is a synthetic small molecule consisting of both lipoic acid and methylenedioxyphenol moieties. It has demonstrated potent anti-atherosclerotic effects in animal studies, where it inhibited the progression of atherosclerosis, improved vascular function, and reduced leukocyte chemotaxis. Its mechanism of action is primarily linked to activation of the Nrf2 (nuclear factor erythroid 2–related factor 2) signaling pathway, which regulates the expression of antioxidant and cytoprotective genes, resulting in reduced oxidative stress and inflammation. LMDP is a research compound and has not been reported as approved for clinical or commercial use[1][5][6].

Other names

lipoicmethylenedioxyphenolLMDP